MediWound's Financial Performance in Q2 2024
MediWound Ltd. has reported a strong financial performance in the second quarter of 2024, showcasing significant progress in its product pipeline and strategic collaborations. The completion of a new manufacturing facility for its flagship product, NexoBrid, is expected to boost production capacity sixfold to meet the rising global demand.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
